UBS Group’s Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) CYTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,711
Closed -$1.9K 9177
2024
Q2
$1.9K Buy
+1,711
New +$1.9K ﹤0.01% 7298
2024
Q1
Sell
-6,814
Closed -$23.7K 9003
2023
Q4
$23.7K Buy
+6,814
New +$23.7K ﹤0.01% 5797
2023
Q2
Sell
-77
Closed -$1.96K 8849
2023
Q1
$1.96K Sell
77
-115
-60% -$2.93K ﹤0.01% 7516
2022
Q4
$18.7K Buy
192
+172
+860% +$16.7K ﹤0.01% 6546
2022
Q3
$2K Sell
20
-45
-69% -$4.5K ﹤0.01% 8730
2022
Q2
$13K Buy
65
+56
+622% +$11.2K ﹤0.01% 6553
2022
Q1
$4K Sell
9
-9
-50% -$4K ﹤0.01% 8309
2021
Q4
$13K Buy
18
+8
+80% +$5.78K ﹤0.01% 7369
2021
Q3
$8K Buy
10
+6
+150% +$4.8K ﹤0.01% 7095
2021
Q2
$5K Buy
+4
New +$5K ﹤0.01% 7488
2021
Q1
Hold
0
8361
2020
Q4
Hold
0
7752
2020
Q3
Sell
-3
Closed -$1K 7510
2020
Q2
$1K Sell
3
-16
-84% -$5.33K ﹤0.01% 6970
2020
Q1
$6K Buy
+19
New +$6K ﹤0.01% 6330
2019
Q4
Sell
-2
Closed -$2K 7263
2019
Q3
$2K Buy
+2
New +$2K ﹤0.01% 6797
2019
Q2
Sell
-2
Closed -$6K 7212
2019
Q1
$6K Buy
2
+1
+100% +$3K ﹤0.01% 6278
2018
Q4
$3K Buy
+1
New +$3K ﹤0.01% 6814
2018
Q3
Sell
-2
Closed -$10K 7233
2018
Q2
$10K Buy
+2
New +$10K ﹤0.01% 6230
2018
Q1
Hold
0
6673
2017
Q3
Hold
0
-$22K 6957
2017
Q2
Hold
0
-$2K 5300
2017
Q1
Hold
0
6385
2016
Q3
Hold
0
-$33K 6898
2016
Q2
Hold
0
5002
2016
Q1
Hold
0
-$7K 6935
2015
Q4
Hold
0
-$21K 6202
2015
Q3
Hold
0
-$31K 5401
2015
Q2
Hold
0
-$4K 5153
2015
Q1
Hold
0
6288